© 2014 AMICUS SA. All rights reserved. Terms of Use. Privacy Policy
Trinomia Polypill (Atorva, Ramipril & ASA) and Sutril Neo (Torasemide SR loop diuretic) – territory non-EU former Yogoslavia & Baltics for EU’s first polypill (largely private market / high copay)
Perfecta, Ellanse, Kelocote and Silhouette: Sinclair IS Pharma is partnering its highly innovative aesthetics portfolio with Amicus, including fillers, collagen stimulators, and novel sutures for a non- invasive facelift, and a new generation silicon-based scar-healing product. Med derma portfolio in negotiations. All former Yugoslavia
Sideral, Sideral Forte, Sideral Folico and Sideral Infant: these first-in-class liposomal-wrapped, oral iron products swept the market wherever launched: Sideral is used in nephrology, early paed, hemo/onco and OB/GYN. All former Yugoslavia
Centrum: Full line of multivitamins plus lutein. Takeover Dec 1, 2014; responsible for launch of Centrum Gender
The Mustela brand family is Europe’s leader in skin care products for babies, children and young mothers.  Territory: Non-EU W. Balkans - Serbia, Montenegro, Macedonia and Bosnia-Herzegovina
Line of Optha products from SOOFT of Italy –  large portfolio of ophthalmic products, RX and Med Device. Available for all of former Yugoslavia
Tricovel Line of EBM derma products for hair loss which sell above 60m Euros in Italy. Also Monoderm line of topical, non-invasive vitamin products and Lichtena – a full line of medically-oriented dermocosmetics.  Non-EU former Yugoslavia
APR - Halykoo Line: innovative pharmacy line of niche children products such as travel sickness, cough & cold eucalyptus patch & teething.  Also an ondansetron film unique dosage form
IFC (Spain) Neo Retin: this is a skin-whitening retinoid derma products with cosmetic registration, but medical claims. Former Yugoslavia and Baltics.  We are also looking to expand relation to other products: Immuno- Feron (food for immuno-suppressed), Viredex (acne) and Renin-Care (mechanical peeling for lightening of skin)
A Swiss Pharmaceutical Company
UPSA,  BioPharma and Rx Innovative Portfolio – 5 year contract signed June, 2015 for all of former Yugoslavia and Baltic states. Existing sales, covers OTC, Onco, Hemo, RA and anti-viral franchises.  Go-live date of takeover is October 1, 2015
Lactalis – world leader in infant nutrition will sign with Amicus to launch its pharmacy portfolio (Celia Expert, Prema, Digest/Allergy and  Mama lines) in non-EU former Yugoslavia
Alcon – Optha and Surgical Portfolio for Serbia and Montenegro: Novartis subsidiary determined to exit Serbian market in early 2015 and has requested that Amicus take over this business
Grafalon (previously ATG Fresenius) - for all ex-Yugo - induction therapy in stem cell and solid organ transplantation with current sales of 1M Euros. Negotiations on-going for Baltic states.
General Electric Healthcare’s Contrast Media business in Serbia and Montenegro, a 2M Euro business in X-ray/CT.  We are working with GE’s contrast media products Visipague, Omnipaque and Omniscan
Licensing and supply contract signed mid-2016 for Salvat’s two anti-infective products for external ear infections – Cetraxal and Cetraxal Plus for all of non- EU ex-Yugo.  Registration underway; launch expected in 2017.
In late June, 2016 Amicus signed a licensing and supply contracts to in-license, for resale under Amicus’ own brand, furazidin for urinary  tract infections.  This will mark the first registration and launch of this compound in the territory is the whole of former Yugoslavia – 22 million people and a 3.5  billion Euro pharmaceutical market.